BioSpace News Archive

Diabetes requires management 24 hours a day, seven days a week, 365 days of the year and presents numerous daily challenges, particularly for families of young children and for adolescents and young adults with type 1 diabetes (T1D)

June 10, 2019 16:36 UTC FDA Grants Genentech’s Polivy Accelerated Approval for People with Previously Treated Aggressive Lymphoma – New targeted medicine shown to improve clinical outcomes in people with relapsed or refractory diffuse large B-cell lymphoma compared to a commonly used regimen – – First-in-class antibody-drug conjugate that specifically targets CD79b, a protein expressed in the majority of B-cells –

A new post-hoc analysis of data from the EMPA-REG OUTCOME® trial indicates a consistent effect of Jardiance® (empagliflozin) on reducing cardiovascular and renal risk in adults with type 2 diabetes and known cardiovascular disease, who also have a form of chronic kidney disease without overt proteinuria (high levels of protein in the urine), as well as others in the trial

Riverchase Dermatology and Cosmetic Surgery, a leading dermatology group and provider of comprehensive skin care services in Florida announces the expansion of their Clinical Research Center within Bowes Dermatology by Riverchase.